The feasibility of using ursodeoxycholic acid in the treatment of patients with non-alcoholic fatty liver disease: a clinical case
Journal Title: Гастроентерологія - Year 2018, Vol 52, Issue 3
Abstract
Non-alcoholic fatty liver disease (NAFLD) is on a leading position among chronic liver diseases. In addition, the pathogenesis of NAFLD has not been fully studied for today. Some authors suggest that NAFLD is one of the components of metabolic syndrome (MS), considering it as a liver manifestation of MS. The article presents current views on the treatment of patients with NAFLD. The theoretical aspects of using ursodeoxycholic acid (UDCA) and the possibility of its application in patients with a combination of NAFLD and MS are also presented. As an example, the feasibility and efficacy of UDCA administration to the patient L. with NAFLD and MS (glucose intolerance, arterial hypertension, obesity) has been demonstrated. The prescription of Ursofalk to the patient L. is pathogenetically grounded due to the hypocholesterolemic, cytoprotective, antioxidant, anticholestatic and other its beneficial effects. UDCA can be considered as an effective and safe drug for the treatment of patients not only with NAFLD, but also with MS, diseases of the cardiovascular system and obesity.
Authors and Affiliations
Ye. S. Sirchak
Keywords
Related Articles
- EP ID EP388619
- DOI 10.22141/2308-2097.52.3.2018.141848
- Views 57
- Downloads 0
Exocrine Pancreatic Insufficiency in Diabetes Mellitus: Incidence, Pathogenesis, Diagnosis and Treatment
The article deals with exocrine pancreatic insufficiency (EPI), which is being detected in a significant number (30–50 %) of patients with diabetes mellitus (DM) type I and II and could potentially affect the compensatio...
Characteristics of changes in lipid and carbohydrate metabolism indices in patients with morbid obesity before and after surgical treatment depending on the type of surgical intervention
Background. Obesity is a chronic metabolic disease that is manifested by excessive development of adipose tissue, which has a certain range of complications and a high risk of relapse after the end of treatment. The asso...
Oxidant-Antioxidant Homeostasis in Gastroduodenopathies Induced by Nonsteroidal Anti-Inflammatory Drugs in Patients with Osteoarthritis Taking into Account the Pathogenic Helicobacter pylori Strains
The role of Helicobacter pylori (Hp) in pathogenetic mechanisms of gastroduodenopathies (GDP) caused by nonsteroidal anti-inflammatory drugs (NSAIDs) in patients with osteoarthritis (OA) is ambiguous. The aim of the work...
Normalization of Biotopes in the Residents of Industrial Centers by Using Probiotics
A comparative analysis of different biotopes of the residents of large industrial city with high anthropogenic load and medium-sized town has been carried out. There were proved the differences in the ratio of microorgan...
The Efficacy of Eradication of Helicobacter pylori Infection in Primary Prevention of NSAID-induced Gastropathy
With the aim of clarifying the efficacy of eradication therapy for Helicobacter pylori (Hp) infection in primary prevention of NSAID-induced gastropathy, we have examined 39 Hp-positive patients, in whom we planned to ad...